These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. A randomized, double-blind, placebo-controlled trial: intravenous immunoglobulin treatment in patients with diffuse cutaneous systemic sclerosis. Takehara K; Ihn H; Sato S Clin Exp Rheumatol; 2013; 31(2 Suppl 76):151-6. PubMed ID: 23910617 [TBL] [Abstract][Full Text] [Related]
11. Safety and tolerability of intravenous immunoglobulin in patients with active dermatomyositis: results from the randomised, placebo-controlled ProDERM study. Aggarwal R; Schessl J; Charles-Schoeman C; Bata-Csörgő Z; Dimachkie MM; Griger Z; Moiseev S; Oddis CV; Schiopu E; Vencovský J; Beckmann I; Clodi E; Levine T; Arthritis Res Ther; 2024 Jan; 26(1):27. PubMed ID: 38233885 [TBL] [Abstract][Full Text] [Related]
12. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy. Eftimov F; Winer JB; Vermeulen M; de Haan R; van Schaik IN Cochrane Database Syst Rev; 2009 Jan; (1):CD001797. PubMed ID: 19160200 [TBL] [Abstract][Full Text] [Related]
13. Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: a double blind, placebo controlled study. Vermeulen M; van Doorn PA; Brand A; Strengers PF; Jennekens FG; Busch HF J Neurol Neurosurg Psychiatry; 1993 Jan; 56(1):36-9. PubMed ID: 8429321 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of high-dose intravenous immunoglobulin therapy for peripheral neuropathy in the remission stage of eosinophilic granulomatosis with polyangiitis (EGPA, Churg-Strauss syndrome). Matsuda T; Arimura Y; Yoshihara K; Komagata Y; Kaname S; Yamada A Nihon Rinsho Meneki Gakkai Kaishi; 2013; 36(4):217-25. PubMed ID: 23994800 [TBL] [Abstract][Full Text] [Related]
15. A double-blind placebo-controlled pilot study of immunoglobulin for small fiber neuropathy associated with TS-HDS and FGFR-3 autoantibodies. Gibbons CH; Rajan S; Senechal K; Hendry E; McCallister B; Levine TD Muscle Nerve; 2023 May; 67(5):363-370. PubMed ID: 36367813 [TBL] [Abstract][Full Text] [Related]
16. Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulins: a double blind, placebo controlled study. Van den Berg LH; Kerkhoff H; Oey PL; Franssen H; Mollee I; Vermeulen M; Jennekens FG; Wokke JH J Neurol Neurosurg Psychiatry; 1995 Sep; 59(3):248-52. PubMed ID: 7673950 [TBL] [Abstract][Full Text] [Related]
17. Randomised placebo-controlled trial of monthly intravenous immunoglobulin therapy in relapsing-remitting multiple sclerosis. Austrian Immunoglobulin in Multiple Sclerosis Study Group. Fazekas F; Deisenhammer F; Strasser-Fuchs S; Nahler G; Mamoli B Lancet; 1997 Mar; 349(9052):589-93. PubMed ID: 9057729 [TBL] [Abstract][Full Text] [Related]
18. An 'n-of-1' placebo-controlled crossover trial of intravenous immunoglobulin as adjuvant therapy in refractory pemphigus vulgaris. Arnold DF; Burton J; Shine B; Wojnarowska F; Misbah SA Br J Dermatol; 2009 May; 160(5):1098-102. PubMed ID: 19222460 [TBL] [Abstract][Full Text] [Related]
19. Intravenous immunoglobulin therapy for small fiber neuropathy: study protocol for a randomized controlled trial. de Greef BT; Geerts M; Hoeijmakers JG; Faber CG; Merkies IS Trials; 2016 Jul; 17(1):330. PubMed ID: 27439408 [TBL] [Abstract][Full Text] [Related]
20. Intravenous immunoglobulin treatment in childhood encephalitis (IgNiTE): a randomised controlled trial. Hill M; Iro M; Sadarangani M; Absoud M; Cantrell L; Chong K; Clark C; Easton A; Gray V; Kneen R; Lim M; Liu X; Pike M; Solomon T; Vincent A; Willis L; Yu LM; Pollard AJ; BMJ Open; 2023 Nov; 13(11):e072134. PubMed ID: 37945292 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]